ZVRA Zevra Therapeutics Forecast, Technical & Fundamental Analysis
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases... Show more
ZVRA is expected to report earnings to fall 81.12% to 11 cents per share on August 18
Q2'26
Est.
$0.11
Q1'26
Beat
by $0.53
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.02
Q2'25
Missed
by $2.25
The last earnings report on May 06 showed earnings per share of 60 cents, beating the estimate of 7 cents. With 1.72M shares outstanding, the current market capitalization sits at 747.81M.
A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with XERS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then XERS could also see price increases.
Momentum Indicator for ZVRA turns positive, indicating new upward trend
ZVRA saw its Momentum Indicator move above the 0 level on June 01, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ZVRA just turned positive on June 08, 2026. Looking at past instances where ZVRA's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
ZVRA moved above its 50-day moving average on May 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ZVRA advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 146 cases where ZVRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for ZVRA moved out of overbought territory on June 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where ZVRA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ZVRA broke above its upper Bollinger Band on June 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.634) is normal, around the industry mean (18.720). P/E Ratio (6.294) is within average values for comparable stocks, (36.072). ZVRA's Projected Growth (PEG Ratio) (10.667) is very high in comparison to the industry average of (1.682). ZVRA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (6.083) is also within normal values, averaging (357.550).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
